Clinical trial
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head…
NCT00195078 · Weill Medical College of Cornell University, Other · Terminated
Key facts
| NCT number | NCT00195078 |
|---|---|
| Title | Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer |
| Official title | Phase I-II Study of ZD1839 (IRESSA®), Cisplatin, and External-Beam Radiation Therapy in Patients With Locally Advanced, Non-Metastatic, Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure |
| Interventions | ZD1839 (IRESSA), Cisplatin, Radiation Therapy |
| Enrollment | 29 |
| Start date | Apr 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jul 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: